Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.
Roma C, Rachiglio AM, Pasquale R, Fenizia F, Iannaccone A, Tatangelo F, Antinolfi G, Parrella P, Graziano P, Sabatino L, Colantuoni V, Botti G, Maiello E, Normanno N. Roma C, et al. Among authors: iannaccone a. Cancer Biol Ther. 2016 Aug 2;17(8):840-8. doi: 10.1080/15384047.2016.1195048. Cancer Biol Ther. 2016. PMID: 27261210 Free PMC article.
Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
Carotenuto P, Roma C, Cozzolino S, Fenizia F, Rachiglio AM, Tatangelo F, Iannaccone A, Baron L, Botti G, Normanno N. Carotenuto P, et al. Among authors: iannaccone a. Int J Oncol. 2012 Feb;40(2):378-84. doi: 10.3892/ijo.2011.1221. Epub 2011 Oct 4. Int J Oncol. 2012. PMID: 21971641
The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies.
Esposito C, Rachiglio AM, La Porta ML, Sacco A, Roma C, Iannaccone A, Tatangelo F, Forgione L, Pasquale R, Barbaro A, Botti G, Ciardiello F, Normanno N. Esposito C, et al. Among authors: iannaccone a. Cancer Biol Ther. 2013 Dec;14(12):1143-6. doi: 10.4161/cbt.26340. Epub 2013 Sep 23. Cancer Biol Ther. 2013. PMID: 24025416 Free PMC article.
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
Normanno N, Esposito Abate R, Lambiase M, Forgione L, Cardone C, Iannaccone A, Sacco A, Rachiglio AM, Martinelli E, Rizzi D, Pisconti S, Biglietto M, Bordonaro R, Troiani T, Latiano TP, Giuliani F, Leo S, Rinaldi A, Maiello E, Ciardiello F; CAPRI-GOIM Investigators. Normanno N, et al. Among authors: iannaccone a. Ann Oncol. 2018 Jan 1;29(1):112-118. doi: 10.1093/annonc/mdx417. Ann Oncol. 2018. PMID: 28950295 Free article. Clinical Trial.
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.
Rachiglio AM, Lambiase M, Fenizia F, Roma C, Cardone C, Iannaccone A, De Luca A, Carotenuto M, Frezzetti D, Martinelli E, Maiello E, Ciardiello F, Normanno N. Rachiglio AM, et al. Among authors: iannaccone a. Cancers (Basel). 2019 Jun 20;11(6):859. doi: 10.3390/cancers11060859. Cancers (Basel). 2019. PMID: 31226844 Free PMC article.
EGFR mutations in lung cancer: from tissue testing to liquid biopsy.
Fenizia F, De Luca A, Pasquale R, Sacco A, Forgione L, Lambiase M, Iannaccone A, Chicchinelli N, Franco R, Rossi A, Morabito A, Rocco G, Piccirillo MC, Normanno N. Fenizia F, et al. Among authors: iannaccone a. Future Oncol. 2015;11(11):1611-23. doi: 10.2217/fon.15.23. Future Oncol. 2015. PMID: 26043215 Review.
Targeting the EGFR T790M mutation in non-small-cell lung cancer.
Normanno N, Maiello MR, Chicchinelli N, Iannaccone A, Esposito C, De Cecio R, D'alessio A, De Luca A. Normanno N, et al. Among authors: iannaccone a. Expert Opin Ther Targets. 2017 Feb;21(2):159-165. doi: 10.1080/14728222.2017.1272582. Epub 2016 Dec 23. Expert Opin Ther Targets. 2017. PMID: 28002980 Review.
298 results